Sympatholytic Effect of Thoracic ESP
CompletedNot applicableNCT05723393
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary endpoint of this study was to identify if erector spinae plane bloock (ESPB) demonstrates any sympatholytic effect. The secondary endpoint of this study was to compare the changes of PI value between responders and non-responders.
Study details
- Official title
- Sympatholytic Effect of High Thoracic Erector Spinae Plane Block
- Conditions
- Interventions
- Sponsor
- Keimyung University Dongsan Medical Center
- Start date
- 2023-02-13
- Primary completion
- 2023-07-10
- Sex
- All
- Age range
- from 20 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Complex regional pain syndrome * Post-thoracotomy pain syndrome * Cervical foraminal stenosis * Cervical disc herniation * Herpes zoster Exclusion Criteria: * Pregnacy * Coagulation abormality * Previous spine surgery * Allergy to local anesthetics
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05723393